Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-04-04

FDA Approved: BRIMONIDINE TARTRATE AND TIMOLOL MALEATE — Original Application (Sandoz Inc)

View source ↗

Summary

FDA approves Sandoz Inc's original ANDA for a fixed-dose combination of brimonidine tartrate and timolol maleate to lower intraocular pressure in adults with op…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Brimonidine tartrate and timolol maleate (brimonidine tartrate and timolol maleate)

Snippet

ORIG AP for BRIMONIDINE TARTRATE AND TIMOLOL MALEATE (BRIMONIDINE TARTRATE AND TIMOLOL MALEATE)